BioCryst Pharmaceuticals | Capital Social E Reservas

Equity Capital And Reserves Alterar Data
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



BioCryst Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2024.